Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 9Withdrawn 1Unknown 1Terminated 1Approved for marketing 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 5Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Busulfan 4Antilymphocyte Serum 4fludarabine phosphate 3Polymerase Chain Reaction 3Mycophenolic Acid 3Daunorubicin 3Cyclosporine 3Radiotherapy 2Gene Expression Profiling 2Filgrastim 2DNA Methylation 2sargramostim 1midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1aldesleukin 1Therapeutics 1Tacrolimus 1Reverse Transcriptase Polymerase Chain Reaction 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Microarray Analysis 1Methylprednisolone 1Methotrexate 1Melphalan 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Congenital Abnormalities × Gemtuzumab × Clear all
NCT00091234 2012-07-24

AML-19

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Unknown
279 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡